Order Article Reprints

Lymperis E, Kaloudi A, Kanellopoulos P, de Jong M, Krenning EP, Nock BA, Maina T. Comparing Gly¹¹/dAla¹¹-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the ¹¹¹In-SB3/¹¹¹In-SB4 Radiotracer Pair. Molecules. 2019; 24(6):1015. https://doi.org/10.3390/molecules24061015

Lymperis, Emmanouil, Aikaterini Kaloudi, Panagiotis Kanellopoulos, Marion de Jong, Eric P. Krenning, Berthold A. Nock, and Theodosia Maina. 2019. "Comparing Gly¹¹/dAla¹¹-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the ¹¹¹In-SB3/¹¹¹In-SB4 Radiotracer Pair" Molecules 24, no. 6: 1015. https://doi.org/10.3390/molecules24061015

Lymperis, E., Kaloudi, A., Kanellopoulos, P., de Jong, M., Krenning, E. P., Nock, B. A., & Maina, T. (2019). Comparing Gly¹¹/dAla¹¹-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the ¹¹¹In-SB3/¹¹¹In-SB4 Radiotracer Pair. Molecules, 24(6), 1015. https://doi.org/10.3390/molecules24061015